Nanopharm/Aptar Pharma

Nanopharm, an Aptar Pharma Company, is a world-leading Contract Research Organization (CRO) specializing in orally inhaled and nasal drug product (OINDP) design and development. The company provides product development and analytical testing services, utilizing proprietary in vitro, in silico models and computational pharmacokinetics (PBPK). Aptar Pharma's expanded R&D Centre in France focuses on advancing pharmaceutical innovation for inhaled and nasal delivery systems.